Back
HCI Group Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Sell
45
HCI
HCI Group
Last Price:
91.46
Seasonality Move:
6.2%
Sell
47
RARE
Ultragenyx Pharmaceutical
Last Price:
41.40
Seasonality Move:
-0.9%
Sell
45
HCI Group (HCI)
is a Sell
Is HCI Group a Buy, Sell or Hold?
- The current HCI Group [HCI] share price is $91.51. The Score for HCI is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- HCI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $41.42. The Score for RARE is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
HCI Stock Price Chart
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $41.42
The current trend is relatively stagnant and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.
HCI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.97 | Sell |
| Relative Strength Index (14 RSI): | 31.69 | Sell |
| Chaikin Money Flow: | -36942 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (92.62 - 98) | Sell |
| Bollinger Bands (100): | (95.18 - 112.82) | Sell |
RARE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.45 | Sell |
| Relative Strength Index (14 RSI): | 52.47 | Buy |
| Chaikin Money Flow: | 873891 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (38.82 - 42.02) | Buy |
| Bollinger Bands (100): | (40.78 - 48.78) | Sell |
HCI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 91.84 | Sell |
| 20-day SMA: | 94.53 | Sell |
| 50-day SMA: | 102.23 | Sell |
| 200-day SMA: | 89.05 | Buy |
| 8-day EMA: | 92.11 | Sell |
| 20-day EMA: | 94.64 | Sell |
| 50-day EMA: | 99.27 | Sell |
| 200-day EMA: | 90.91 | Buy |
RARE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.5 | Buy |
| 20-day SMA: | 40.58 | Buy |
| 50-day SMA: | 41.51 | Sell |
| 200-day SMA: | 42.46 | Sell |
| 8-day EMA: | 40.23 | Buy |
| 20-day EMA: | 40.49 | Buy |
| 50-day EMA: | 41.77 | Sell |
| 200-day EMA: | 43.33 | Sell |
HCI Group Earnings Growth & HCI Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.24 per share, an increase next quarter of $1.80 per share, an increase this year of $6.46 per share, and an increase next year of $0.25 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.
HCI Group Technical Analysis
| Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ultragenyx Pharmaceutical Technical Analysis
| Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||